Artiva Biotherapeutics Inc

Research Artiva Biotherapeutics Inc (ARTV) on Bullrun: market cap USD 236.79M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerARTV
• ExchangeNASDAQ
• CountryUnited States
• SectorHealthcare
• IndustryBiotechnology
• CurrencyUSD
• Market capUSD 236.79M
• Financial periodFY2025
• Revenue growth-100.0%
• Net income-USD 83.87M
• Free cash flow-USD 79.34M

Valuation Snapshot

latest market cap is USD 236.79M.

About Artiva Biotherapeutics Inc

Artiva Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing natural killer (NK) cell-based therapies for patients suffering from autoimmune diseases and cancers.

Frequently asked questions

What is Artiva Biotherapeutics Inc's market cap?

Artiva Biotherapeutics Inc's market capitalization is USD 236.79M.

What does Artiva Biotherapeutics Inc do?

Artiva Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing natural killer (NK) cell-based therapies for patients suffering from autoimmune diseases and cancers.